Hon Matt Doocey, Associate Health Minister with responsibility for Rural Health and Minister for Mental Health, will be coming to rural communities in New Zealand to hear about local health care ...

Te Pae Mahutonga is a framework for understanding the elements of Māori health promotion, developed by Tā Mason Durie.

These tables present key health indicators from all years of the continuous New Zealand Health Survey for adults and children, broken down by geographic areas and demographics.

From 1 July 2025, when Pharmac funds a new cancer medicine or widens access to existing funded cancer medicines, eligible patients will be able to receive the publicly funded medicine within private ...

This discussion document considers options for modernising New Zealand’s regulation of the health workforce. It supports public consultation on this topic.

Subscribe to the Public Health Agency quarterly newsletter, Public Health Matters. Sharing the latest about how the Agency is working across the health system and beyond to improve the health of New ...

This briefing provided the incoming Minister of Health, Hon Simeon Brown, with an overview of the context of recent Government reforms and priorities, and identified key issues and upcoming milestones ...

In February 2024, the High Court directed the Director-General of Health to assess whether each of the 14 directions to fluoridate one or more water supplies made in 2022 were, in terms of section 5 ...

This review updates the evidence regarding community water fluoridation published since the 2021 report from the Office of the Prime Minister’s Chief Science Advisor.

The consultation on safety measures for the use of puberty blockers in young people with gender-related health needs closed on 20 January 2025. We will now consider submissions.BackgroundThe ...

This position statement accompanies the release of an evidence brief which examines the safety and long-term impacts of puberty blockers when used in the context of gender-affirming care. This ...

This literature review summarises the latest national and international evidence of the safety and long-term impacts of puberty blockers on adolescents.